Eureka Forbes Q4 FY26 Revenue Up 11.6% to ₹683.8 Crore; Adj. EBITDA Margin at 13.2%
Eureka Forbes reported Q4 FY26 revenue of ₹683.8 Crore, an 11.6% YoY increase, with Adj. EBITDA margin at 13.2%. For FY26, revenue grew 11.3% to ₹2,710.5 Crore, and Adj. EBITDA margin expanded to 12.2%. The company aims for over 2x revenue and over 3x EBITDA in 5 years.
The results show solid growth and improved profitability metrics, which are significant for investors and stakeholders. The company's strategic direction and ambitious future targets also indicate potential for further value creation.
The company reported healthy revenue growth, margin expansion, and strong performance across key categories, indicating positive financial health and operational efficiency. Management commentary also reflects optimism about future growth.
Eureka Forbes Limited announced its financial results for the quarter and full year ended March 31, 2026. For the fourth quarter of FY26, the company reported a revenue growth of 11.6% year-on-year, reaching ₹683.8 Crore. This growth was driven by double-digit expansion in Water Purifiers and strong performance in Emerging Categories, alongside healthy double-digit growth in the products business. The service business also maintained its momentum with double-digit growth in service bookings.
Adjusted EBITDA (Adj. EBITDA) margins for the quarter expanded by 17 basis points year-on-year to 13.2%, with Adj. EBITDA at ₹90.2 Crore. Adjusted Profit Before Tax (Adj. PBT) increased by 8.1% year-on-year to ₹73.5 Crore. Profit After Tax (PAT) before exceptional items grew by 3.9% year-on-year to ₹51.1 Crore, while the reported PAT saw a marginal growth of 0.7% year-on-year.
For the full financial year ended March 31, 2026, Eureka Forbes achieved a double-digit revenue growth of 11.3% for the second consecutive year, amounting to ₹2,710.5 Crore. Gross margins improved by 46 basis points to 58.8%. Adj. EBITDA for the year increased by 16.4% to ₹331.9 Crore, with Adj. EBITDA margin expanding by 55 basis points to 12.2%, marking the third consecutive year of margin expansion despite increased growth investments. PAT before exceptional items grew by 19.3% to ₹190.2 Crore, though the reported PAT decreased by 1.9% to ₹160.2 Crore.
Mr. Pratik Pota, MD and CEO, highlighted the strong performance in a challenging environment, emphasizing the quality of growth, structural progress, and the company's transformation into a multi-category health and hygiene entity. He expressed confidence in delivering sustained, profitable growth through continued investments and sharper execution.
What to do with a filing like this
Eureka Forbes Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Eureka Forbes Limited. Read the original for the full detail.